Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Wai Chun Group Holdings Limited ( (HK:1013) ) has shared an update.
Wai Chun Group Holdings Limited has disclosed that it and its subsidiary Wai Chun Bio-Technology Limited have been ordered by the High Court of Hong Kong to pay Island Sky Limited HK$2,672,193.60 plus interest and legal costs. The sum represents 50% of mesne profits, rent, rates, management and air-conditioning charges for the period from 16 September 2022 to 27 April 2023 relating to office premises at Admiralty Centre.
The board considers the mesne profits claimed to be excessive compared with market comparables and has lodged a Notice of Appeal with the High Court. The company is seeking legal advice on further actions, including applying for a stay of execution and preparing evidence for the appeal, signaling potential financial and legal uncertainty that may affect its obligations and stakeholder interests until the dispute is resolved.
The most recent analyst rating on (HK:1013) stock is a Hold with a HK$0.81 price target. To see the full list of analyst forecasts on Wai Chun Group Holdings Limited stock, see the HK:1013 Stock Forecast page.
More about Wai Chun Group Holdings Limited
Wai Chun Group Holdings Limited is a Bermuda-incorporated company listed on the Hong Kong Stock Exchange. Through subsidiaries including Wai Chun Bio-Technology Limited, it is engaged in commercial operations in Hong Kong, with activities that involve leasing and occupying office premises in major business districts such as Admiralty. The group operates under the oversight of a board comprising one executive director and three independent non-executive directors.
Average Trading Volume: 230,428
Technical Sentiment Signal: Buy
Current Market Cap: HK$240.7M
For an in-depth examination of 1013 stock, go to TipRanks’ Overview page.